Steven Cohen’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$627K Sell
1,200
-400
-25% -$205K ﹤0.01% 3014
2026
Q2
$795K Sell
1,600
-2,000
-56% -$886K ﹤0.01% 2953
2026
Q1
$1.61M Sell
3,600
-3,500
-49% -$1.63M ﹤0.01% 2454
2025
Q4
$3.22M Buy
+7,100
New +$3.06M ﹤0.01% 2153
2025
Q1
– Sell
-20,000
Closed -$8.05M – 2577
2024
Q4
$8.05M Buy
+20,000
New +$9.27M 0.02% 769

Other funds holding VRTX

Steven Cohen's VRTX Position: Q3 2026 in Review

Steven Cohen sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 2,625 shares — an estimated $1.34M sold.

Steven Cohen first reported a position in VRTX in Q2 2014 and held it in 30 quarters. The position peaked at $143M in Q1 2021. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Steven Cohen reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 2,625 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.34M.
  • Steven Cohen first reported a position in Vertex Pharmaceuticals in Q2 2014 and held it in 30 quarters.
  • Steven Cohen's Vertex Pharmaceuticals position peaked at $143M in Q1 2021.
  • 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.